NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $1.43 million. The enterprise value is $7.52 million.
Important Dates
The last earnings date was Sunday, February 16, 2025, before market open.
| Earnings Date | Feb 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 679,681 shares outstanding. The number of shares has increased by 1,250.11% in one year.
| Current Share Class | 679,681 |
| Shares Outstanding | 679,681 |
| Shares Change (YoY) | +1,250.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.04% |
| Owned by Institutions (%) | 17.83% |
| Float | 376,810 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| Forward PS | n/a |
| PB Ratio | -0.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.32 |
| EV / EBITDA | 36.50 |
| EV / EBIT | 46.60 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.28
| Current Ratio | 0.28 |
| Quick Ratio | 0.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | 17.58 |
| Debt / FCF | n/a |
| Interest Coverage | 0.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -8.00% |
| Revenue Per Employee | $81,132 |
| Profits Per Employee | -$1,154 |
| Employee Count | 70 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -83,742 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.36 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.53 |
| 200-Day Moving Average | 14.70 |
| Relative Strength Index (RSI) | 31.35 |
| Average Volume (20 Days) | 2,636,039 |
Short Selling Information
The latest short interest is 340,306, so 50.07% of the outstanding shares have been sold short.
| Short Interest | 340,306 |
| Short Previous Month | 946,192 |
| Short % of Shares Out | 50.07% |
| Short % of Float | 90.31% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $5.68 million and -$80,775 in losses. Loss per share was -$0.21.
| Revenue | 5.68M |
| Gross Profit | 1.48M |
| Operating Income | 161,399 |
| Pretax Income | -690,851 |
| Net Income | -80,775 |
| EBITDA | 206,016 |
| EBIT | 161,399 |
| Loss Per Share | -$0.21 |
Full Income StatementBalance Sheet
The company has $313,740 in cash and $6.40 million in debt, giving a net cash position of -$6.09 million or -$8.95 per share.
| Cash & Cash Equivalents | 313,740 |
| Total Debt | 6.40M |
| Net Cash | -6.09M |
| Net Cash Per Share | -$8.95 |
| Equity (Book Value) | -7.08M |
| Book Value Per Share | -12.98 |
| Working Capital | -2.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.82 million and capital expenditures -$67,799, giving a free cash flow of -$2.89 million.
| Operating Cash Flow | -2.82M |
| Capital Expenditures | -67,799 |
| Free Cash Flow | -2.89M |
| FCF Per Share | -$4.26 |
Full Cash Flow StatementMargins
Gross margin is 26.14%, with operating and profit margins of 2.84% and -1.42%.
| Gross Margin | 26.14% |
| Operating Margin | 2.84% |
| Pretax Margin | -2.16% |
| Profit Margin | -1.42% |
| EBITDA Margin | 3.63% |
| EBIT Margin | 2.84% |
| FCF Margin | n/a |